Journal of pharmacopuncture · 2016 · 10 citations · 31 references
PharmacyPharmacologyToxicologyGenetic ToxicologyMolecular ToxicologyPharmaceutical ToxicologyGenotoxicity AssessmentGenotoxicity MechanismsGenotoxicity Risk AssessmentGenotoxicity TestingMolecular Mechanisms Of ToxicityMutagenicity AssessmentAcute Oral ToxicityAnticancer ActivityChromosome Aberration AssayGeneral ToxicologyGenotoxicityMutagenic MechanismsNo-observed-adverse-effect LevelTarget Organ Toxicity
OBJECTIVES: Ginseng Rh2+ is enzyme-treated ginseng extract containing high amounts of converted ginsenosides, such as compound k, Rh2, Rg3, which have potent anticancer activity. We conducted general and genetic toxicity tests to evaluate the safety of ginseng Rh2+. METHODS: micronucleus test using ICR mice bone marrow as recommended by the Korean Ministry of Food and Drug Safety. RESULTS: in mice bone marrow micronucleus test. CONCLUSION: On the basis of our findings, ginseng Rh2+ is a non-toxic material with no genotoxicity. We expect that ginseng Rh2+ may be used as a novel adjuvant anticancer agent that is safe for long-term administration.
31
Werner Schmid · Mutation Research/Environmental Mutagenesis and Related Subjects · 1975 · 2.3K citations
DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION
Mona Abdel‐Tawab, U. Bahr, Michael Karas et al. · Drug Metabolism and Disposition · 2003 · 438 citations